Print

FDA Approves Beech Tree Labs, Inc.' Influenza IND Application  
1/28/2010 9:09:40 AM

PROVIDENCE, R.I.--(BUSINESS WIRE)--Beech Tree Labs, Inc., announced today that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections.
//-->